FDA issued a Warning Letter to Baxter Healthcare Corp. on 9/10/2009 for a previous inspection.
483 Baxter Healthcare Sep 2016

483 Baxter Healthcare Sep 2016

Debra Love FDA, Bryan Mcguckin FDA$119.00 - Available Now

FDA investigators audited the Baxter Healthcare - Deerfield, IL, United States facility and issued inspectional observations (via FDA 483) on 28 Sep 2016.

Product details

  • Category: Human Drugs
  • Inspection end: 28 Sep 2016
  • Location: Deerfield, United States
  • FEI: 1417572
Add To Cart